LOGO
LOGO

Corporate News

IDEXX Labs Lifts FY25 Outlook Above Market After Q2 Beats Street; Stock Gains In Pre-market

By RTTNews Staff Writer   ✉   | Published:   | Follow Us On Google News

IDEXX Laboratories, Inc. (IDXX), while reporting higher second-quarter results above the Street, on Monday raised its outlook for fiscal 2025 earnings and revenues, both above market estimates.

In the pre-market activity on the Nasdaq, IDEXX shares were gaining around 5 percent to trade at $562.11.

For fiscal 2026, the company now expects earnings per share of $12.40 to $12.76, representing a year-over-year growth of 16 percent to 20 percent. The company previously expected earnings per share of $11.93 to $12.43, a growth of 12 percent to 17 percent from last year.

The Wall Street analysts on average expect the company to report earnings of $12.21 per share. Analysts' estimates typically exclude special items.

The revision reflects certain one-time benefits. The updated outlook is 9 percent to 13 percent growth on a comparable basis.

Further, IDEXX updated the lower end of its full-year reported operating margin outlook, and now expects between 31.3 percent and 31.6 percent from previously expected 31.1 percent to 31.6 percent.

Annual revenue guidance range has been lifted to $4.205 billion to $4.280 billion or reported growth of 7.7 percent to 9.7 percent from last year, an increase of $90 million at midpoint. The previous outlook was $4.095 billion to $4.210 billion, or 5.0 percent - 8.0 percent year-over-year growth.

The Street expects revenues of $4.15 billion.

The Company lifted the lower end of outlook for organic revenue growth to 7 percent to 9 percent from previous view of 6 percent to 9 percent.

In the second quarter, IDEXX's net income totaled $293.99 million or $3.63 per share, compared to $203.30 million, or $2.44 per share, last year.

Adjusted earnings of $3.50 per share for the period. Analysts had expected the company to earn $3.30 per share.

The company's revenue for the period rose 10.6 percent to $1.109 billion from $1.003 billion last year. The Street was looking for revenues of $1.07 billion.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Biotech Investor.
Global Economics Weekly Update: April 13 – April 17, 2026

April 17, 2026 15:29 ET
The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.